EP3423076
Staðbundnar samsetningar sem innihalda sýklósporín og notkun þeirra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.2.2017EP published:
17.4.2024EP application number:
17760643.1
EP translation filed:
26.6.2024Grant published:
15.7.2024EPO information:
European Patent Register
Max expiry date:
27.2.2037Expiry date:
27.2.2027Next due date:
28.2.2027
Title in English:
TOPICAL CYCLOSPORINE-CONTAINING FORMULATIONS AND USES THEREOFLanguage of the patent:
English
Timeline
Today
28.2.2017EP application
17.4.2024EP Publication
26.6.2024Translation submitted
15.7.2024Registration published
27.2.2027Expires
Owner
Name:
Sun Pharmaceutical Industries LimitedAddress:
Sun House Plot No. 201 B/1 Western Express Highway Goregaon (E), Mumbai, Maharashtra 400 063, IN
Inventor
Name:
WEISS, Sidney L.Address:
Randolph, New Jersey 07869, US
Name:
MITRA, Ashim K.Address:
Overland Park, Kansas 66221, US
Name:
MCNALLY, Eugene J.Address:
Fitchburg, Wisconsin 53711, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662301576 PDate:
29.2.2016Country:
US
Number:
201662302058 PDate:
1.3.2016Country:
US
Number:
201662302730 PDate:
2.3.2016Country:
US
Number:
201662311177 PDate:
21.3.2016Country:
US
Classification
Categories:
A61K 9/00, A61K 38/13, A61P 27/02, A61K 9/107, A61K 47/10, A61K 47/44
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 11.2.2025
Expires: 27.2.2026
Payer: Árnason Faktor ehf.
Number: 10
Paid: 16.2.2026
Expires: 27.2.2027
Payer: Árnason Faktor ehf.